CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND)

Registered charity 1158672 · accounts filings on the Charity Commission register · also known as SOHANA RESEARCH FUND, SRF

SRF seeks to assist those suffering from Epidermolysis Bullosa ("EB"), in particular but not exclusively by making grants:(1) to fund medical research and/or clinical trials anywhere in the world for the purpose of discovering, developing and delivering treatments for EB; and(2) to fund the treatment of patients who are suffering from EB.

Objects

FOR THE PUBLIC BENEFIT, (A) THE ADVANCEMENT OF HEALTH AND (B) THE RELIEF AND ASSISTANCE OF PEOPLE IN NEED WHO ARE SUFFERING FROM EPIDERMOLYSIS BULLOSA, IN PARTICULAR BUT NOT EXCLUSIVELY BY MAKING GRANTS: (1) TO FUND MEDICAL RESEARCH AND/OR CLINICAL TRIALS ANYWHERE IN THE WORLD FOR THE PURPOSE OF DISCOVERING, DEVELOPING AND DELIVERING TREATMENTS FOR EPIDERMOLYSIS BULLOSA; AND (2) TO FUND THE TREATMENT OF PATIENTS WHO ARE SUFFERING FROM EPIDERMOLYSIS BULLOSA. NOTHING IN THIS CONSTITUTION SHALL AUTHORISE AN APPLICATION OF THE PROPERTY OF THE CIO FOR THE PURPOSES WHICH ARE NOT CHARITABLE IN ACCORDANCE WITH SECTION 7 OF THE CHARITIES AND TRUSTEE INVESTMENT (SCOTLAND) ACT 2005 OR SECTION 2 OF THE CHARITIES ACT (NORTHERN IRELAND) 2008.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · Disability · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Islington, London, England (from the postcode on the register)

Latest income
£3.5m
Latest spending
£1.3m
Registered
2014
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that Cure EB held unrestricted and restricted reserves of £7,381,688 at year-end, significantly exceeding its operating costs due to substantial donations. The charity reported a net movement in funds of £2,256,136, with gross income of £3,548,376 against charitable expenditure of £1,208,298. The trustees confirmed adequate resources to continue operations, noting that reserves substantially exceeded commitments.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Related-party transaction: Donations from Trustees
“In the year there were donations to the Charity from the Trustees amounting to £250,204 (2024: £1,247,865) (which are increased by Cure EB claiming Gift Aid).” — page 28
“During the year the Charity introduced £38,166 (2024: £638,664) of support to its subsidiary EB Therapeutics Ltd.” — page 28
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Support to subsidiary EB Therapeutics Ltd
“In the year there were donations to the Charity from the Trustees amounting to £250,204 (2024: £1,247,865) (which are increased by Cure EB claiming Gift Aid).” — page 28
“During the year the Charity introduced £38,166 (2024: £638,664) of support to its subsidiary EB Therapeutics Ltd.” — page 28
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Mitchell Charlesworth (Audit) Limited. Discloses 4 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/12/2025

  • Volunteers: 20
  • Has a trading subsidiary
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2024

  • Volunteers: 15
  • Has a trading subsidiary
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2023

  • Volunteers: 15
  • Has a trading subsidiary
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — Cure EB (matched by registered charity number).

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/12/2025)

Total income
£3.5m
Total spending
£1.3m
Cost of raising funds
£84k
Reserves (reported)
£7.4m
Employees
0

Reported reserves equal ~68.5 months of spending — in the top quarter for charities its size (median 4.7 months; benchmarks).

Per its annual return, largest income source: Donations and legacies (98% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 2.4% of total income — below the median for charities its size (5.3%) (benchmarks).

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: France · Spain · Throughout England And Wales · United States

Income and spending

Financial year endIncomeSpending
31/12/2025£3.5m£1.3m
31/12/2024£4.9m£1.4m
31/12/2023£731k£1.6m
31/12/2022£1.0m£1.1m
31/12/2021£1.6m£859k

Common questions

Is CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND) financially healthy?

Per its FY2025 accounts: The accounts state that Cure EB held unrestricted and restricted reserves of £7,381,688 at year-end, significantly exceeding its operating costs due to substantial donations. The charity reported a net movement in funds of £2,256,136, with gross income of £3,548,376 against charitable expenditure of £1,208,298. The trustees confirmed adequate resources to continue operations, noting that reserves substantially exceeded commitments. Its FY2025 accounts were audited by Mitchell Charlesworth (Audit) Limited.

Who funds CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND)?

Funders whose own accounts filings name CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND) as a grant recipient include THE REED FOUNDATION.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmountPurpose (as stated by the funder)
THE REED FOUNDATIONFY2022£11kChristmas Challenge
THE REED FOUNDATIONFY2021amount not stated

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with DEBRA.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
CURE EB (FORMERLY KNOWN AS SOHANA RESEARCH FUND)£3.5m—0unclear—no doubt
DEBRA FY2025£17.6m£140,001 - £150,000—unclear—no doubt
CURE LEUKAEMIA FY2025£3.7m——unclear—no doubt
THE SKIN CANCER RESEARCH FUND FY2025£39k—0unclear24.8%no doubt
BRITISH SOCIETY OF ENDOVASCULAR THERAPY FY2026£364k—0above—no doubt
SOLEBAY CARE FUND FY2025£91k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.